Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization

Table 4 Treatment and intervention, n (%)

	MACE group (n = 20)	Event-free group (n = 30)	P value
Diuretics	14 (70)	22 (73.3)	0.797
Inotropic agents	14 (70)	9 (30)	0.005
Vasoactive agents	20 (100)	11 (36.7)	< 0.001
Glucocorticoid	6 (30)	10 (33.3)	0.804
Immune globulin	6 (30)	8 (26.7)	0.797
Temporary pacemaker	5 (25)	8 (26.7)	0.895
Ventilator	13 (65)	1 (3.3)	< 0.001
CRRT	9 (45)	0 (0)	< 0.001
ECMO	9 (45)	1 (3.3)	0.001
IABP	6 (30)	0 (0)	0.002

MACE: Major adverse cardiovascular events; CRRT: Continuous renal replacement therapy; ECMO: Extracorporeal membrane oxygenation; IABP: Intra-aortic balloon pump.